<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(4)</volume><submitter>McLeish E</submitter><funding>Brain Foundation</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4>Inclusion body myositis (IBM) is a progressive late-onset muscle disease characterised by preferential weakness of quadriceps femoris and finger flexors, with elusive causes involving immune, degenerative, genetic and age-related factors. Overlapping with normal muscle ageing makes diagnosis and prognosis problematic.&lt;h4>Methods&lt;/h4>We characterised peripheral blood leucocytes in 81 IBM patients and 45 healthy controls using flow cytometry. Using a random forest classifier, we identified immune changes in IBM compared to HC. K-means clustering and the random forest one-versus-rest model classified patients into three immunophenotypic clusters. Functional outcome measures including mTUG, 2MWT, IBM-FRS, EAT-10, knee extension and grip strength were assessed across clusters.</pubmed_abstract><journal>Clinical &amp; translational immunology</journal><pagination>e1504</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10990804</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models.</pubmed_title><pmcid>PMC10990804</pmcid><pubmed_authors>Beer K</pubmed_authors><pubmed_authors>Cooper I</pubmed_authors><pubmed_authors>Mastaglia FL</pubmed_authors><pubmed_authors>Needham M</pubmed_authors><pubmed_authors>Sooda A</pubmed_authors><pubmed_authors>Coudert JD</pubmed_authors><pubmed_authors>Slater N</pubmed_authors><pubmed_authors>McLeish E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models.</name><description>&lt;h4>Objective&lt;/h4>Inclusion body myositis (IBM) is a progressive late-onset muscle disease characterised by preferential weakness of quadriceps femoris and finger flexors, with elusive causes involving immune, degenerative, genetic and age-related factors. Overlapping with normal muscle ageing makes diagnosis and prognosis problematic.&lt;h4>Methods&lt;/h4>We characterised peripheral blood leucocytes in 81 IBM patients and 45 healthy controls using flow cytometry. Using a random forest classifier, we identified immune changes in IBM compared to HC. K-means clustering and the random forest one-versus-rest model classified patients into three immunophenotypic clusters. Functional outcome measures including mTUG, 2MWT, IBM-FRS, EAT-10, knee extension and grip strength were assessed across clusters.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2026-07-16T21:16:03.055Z</modification><creation>2025-04-07T12:45:01.79Z</creation></dates><accession>S-EPMC10990804</accession><cross_references><pubmed>38585335</pubmed><doi>10.1002/cti2.1504</doi></cross_references></HashMap>